Page last updated: 2024-10-29

ketanserin and Age-Related Memory Disorders

ketanserin has been researched along with Age-Related Memory Disorders in 1 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Research Excerpts

ExcerptRelevanceReference
"Ketanserin caused an increase in AEA concentrations, 180 min after administration."2.87Peripheral endocannabinoid concentrations are not associated with verbal memory impairment during MDMA intoxication. ( de la Torre, R; Farre, M; Haijen, E; Kuypers, KPC; Olesti, E; Pastor, A; Pizarro, N; Ramaekers, JG, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haijen, E1
Farre, M1
de la Torre, R1
Pastor, A1
Olesti, E1
Pizarro, N1
Ramaekers, JG1
Kuypers, KPC1

Trials

1 trial available for ketanserin and Age-Related Memory Disorders

ArticleYear
Peripheral endocannabinoid concentrations are not associated with verbal memory impairment during MDMA intoxication.
    Psychopharmacology, 2018, Volume: 235, Issue:3

    Topics: Adult; Arachidonic Acids; Double-Blind Method; Endocannabinoids; Female; Humans; Ketanserin; Male; M

2018